The global neurostimulation devices market is expected to be valued at USD 13.70 Billion by 2027 from USD 5.60 billion in 2019, registering a CAGR of 12.6% through the forecast period. Growing prevalence of several neurological disorders including Dystonia, epilepsy, and Parkinson’s diseasesis creating need for advanced neurostimulation devices. Further technological advancement coupled with robust investment in the healthcare infrastructure across the globe are encouraging introduction and adoption of newer technologies, which is driving growth of the neurostimulation devices market.
The latest study unravels the unfavorable impacts of the COVID-19 pandemic on the global Neurostimulation Devices business sector. According to our expert team, the corona virus outbreak has had an overwhelming impact on the global economic landscape, and consequently, on this business vertical. The pandemic is expected to contribute to the potential downturn of the Neurostimulation Devices industry substantially. Reportedly, this sector has been financially beleaguered since the COVID-19 lockdown restrictions were put into effect. Hence, the report highlights the financial obstacles that have slowed numerous businesses’ progress in this sector and disrupted the global supply chains.
Competitive Overview:
The global Neurostimulation Devices market report closely studies the functioning mechanisms of the key companies participating in the global market. These companies are said to be following a slew of business expansion strategies to reinforce their financial positions in this market. As per the report, these companies account for a major portion of the overall Neurostimulation Devices market share. Therefore, this section of the report emphasizes the principal strategic initiatives led by these companies, including mergers & acquisitions, joint ventures, new business deals, new product launches, collaborations, technological upgradation, and several others.
Key Market Players:
St. Jude Medical, Boston Scientific Corporation, Medtronic, Neuronetics, Inc., Nevro Corporation, Codman & Shurtleff, Inc., Intrapace, LivaNovaplc, Abbott Laboratories, and Bayer AG.
Global Neurostimulation Devices Market Report – Table of Contents:
- Report Overview
1.1 Research Scope
1.2 Key Neurostimulation Devices market segments
1.3 Target players
1.4 Market analysis by type
1.5 Market analysis by application
1.6 Key learning objectives
1.7 Report timeline
- Global Growth Trends
2.1 Global Neurostimulation Devices market size
2.2 Latest trends of the Neurostimulation Devices market by region
2.3 Key corporate trends
- Global Neurostimulation Devices Market share by key players
3.1 Global Neurostimulation Devices Market size by manufacturers
3.2 Global Neurostimulation Devices Market key players
3.3 Products/solutions/services of major players
3.4 New entrants in the Neurostimulation Devices market
3.5 Mergers, acquisitions, joint ventures, and expansion plans
- Global Neurostimulation Devices Market by product type
4.1 Global Neurostimulation Devices Sales by Product
4.2 Global Neurostimulation Devices by Product Revenue
Download the full Neurostimulation Devices market description@ https://www.emergenresearch.com/industry-report/neurostimulation-devices-market
Thank you for reading our report. For further details or to inquire about customization, please let us know, and we will offer you the report well-suited to your requirements.
